SCHEMBL3570835

SCHEMBL3570835

CC(=O)c1cccc(Nc2ccc3c(c2)C(=CNc2ccc(CN4CCCCC4)cc2)C(=O)NC3=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
RAB9A P51151 3/20 0.41
HTT P42858 2/20 0.41
GAA P10253 1/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 3/20 0.39
KMT2A Q03164 3/20 0.39
ATM Q13315 1/20 0.39
CDK4 P11802 1/20 0.38
CCND1 P24385 1/20 0.38
RET P07949 1/20 0.38
CASP3 P42574 1/20 0.38
CASP2 P42575 1/20 0.38
CASP7 P55210 1/20 0.38
CASP6 P55212 1/20 0.38
CASP8 Q14790 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3570829 1.00 ALDH1A1 (0.45) ALDH1A1CYP1A2CYP3A4NPSR1RAB9A
SCHEMBL3565551 0.92 HRH3 (0.43) ALDH1A1KDM4ELMNAKMT2ACDK4
SCHEMBL3565548 0.92 HRH3 (0.43) ALDH1A1KDM4ELMNAKMT2ACDK4
SCHEMBL3562950 0.88 KDM4E (0.39) ALDH1A1RAB9AHTTGAAKDM4E
SCHEMBL3562952 0.88 KDM4E (0.39) ALDH1A1RAB9AHTTGAAKDM4E
SCHEMBL3567788 0.88 CDK4 (0.46) ALDH1A1CYP3A4NPSR1GAAKDM4E
SCHEMBL3567794 0.88 CDK4 (0.46) ALDH1A1CYP3A4NPSR1GAAKDM4E
SCHEMBL13343880 0.87 KDM4E (0.57) ALDH1A1KDM4ELMNAKMT2ACDK4
SCHEMBL3574367 0.86 ALDH1A1 (0.41) ALDH1A1RAB9AHTTGAAKDM4E
SCHEMBL3572930 0.86 CDK4 (0.38) ALDH1A1RAB9AHTTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US claimed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US claimed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 ALDH1A1 61/4885CYP1A2 147/4885CYP3A4 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.